TreeFrog Therapeutics receives additional €3M non-dilutive funding to mass-produce clinical-grade cell therapies by 2021
Imcyse reports successful first-in-human Phase 1b study in type 1 diabetes with IMCY-0098
Imcyse announces changes in management and board, appoints Thomas Taapken as executive chairman
Alizé Pharma 3 raises €67 million ($75 million) in Series A from a strong international syndicate
Pherecydes Pharma and BIOASTER join forces to explore the use of phage therapy to treat complicated urinary tract infections
Domain Therapeutics appoints Xavier Leroy as chief technology officer
GamaMabs Pharma announces presentation of murlentamab phase 2 study results in colorectal cancer at ESMO World Congress on Gastrointestinal Cancer
Nosopharm and Evotec enter into collaboration toaccelerate development of novel antibiotics
